Microbiota-related Metabolites Fueling the Understanding of Ischemic Heart Disease

Overview

Journal Imeta

Specialty Biology

Date 2024 Jun 13

PMID 38868424

Authors

Yong Fan

Jiajun Ying

Hongchuang Ma

Hanbin Cui

Affiliations

Soon will be listed here.

Abstract

Up-to-date knowledge of gut microbial taxa associated with ischemic heart disease (IHD). Microbial metabolites for mechanistic dissection of IHD pathology. Microbiome-based therapies in IHD prevention and treatment.

Citing Articles

Gut microbiome related to metabolic diseases after moderate-to-vigorous intensity exercise.

Yun S, Seo Y, Lee Y, Lee D J Exerc Sci Fit. 2024; 22(4):375-382.

PMID: 39185003 PMC: 11342187. DOI: 10.1016/j.jesf.2024.07.003.

Visualizing set relationships: EVenn's comprehensive approach to Venn diagrams.

Yang M, Chen T, Liu Y, Huang L Imeta. 2024; 3(3):e184.

PMID: 38898979 PMC: 11183158. DOI: 10.1002/imt2.184.

Fan Y, Ying J, Ma H, Cui H Imeta. 2024; 2(2):e94.

PMID: 38868424 PMC: 10989774. DOI: 10.1002/imt2.94.

Gut microbiota in heart failure and related interventions.

Chen A, Zhang J, Zhang Y Imeta. 2024; 2(3):e125.

PMID: 38867928 PMC: 10989798. DOI: 10.1002/imt2.125.

The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review.

Sun C, Zhu D, Zhu Q, He Z, Lou Y, Chen D Front Cell Infect Microbiol. 2024; 14:1337223.

PMID: 38404291 PMC: 10884129. DOI: 10.3389/fcimb.2024.1337223.

References

Qi Y, Jiang C, Cheng J, Krausz K, Li T, Ferrell J . Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice. Biochim Biophys Acta. 2014; 1851(1):19-29. PMC: 4219936. DOI: 10.1016/j.bbalip.2014.04.008. View

Tang T, Chen H, Chen C, Yen C, Lin C, Prajnamitra R . Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair. Circulation. 2018; 139(5):647-659. DOI: 10.1161/CIRCULATIONAHA.118.035235. View

Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L . The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011; 8(2):110-20. PMC: 4003137. DOI: 10.1038/cmi.2010.67. View

Mailer R, Gistera A, Polyzos K, Ketelhuth D, Hansson G . Hypercholesterolemia Induces Differentiation of Regulatory T Cells in the Liver. Circ Res. 2017; 120(11):1740-1753. DOI: 10.1161/CIRCRESAHA.116.310054. View

Chambers E, Byrne C, Morrison D, Murphy K, Preston T, Tedford C . Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised.... Gut. 2019; 68(8):1430-1438. PMC: 6691855. DOI: 10.1136/gutjnl-2019-318424. View

Fromentin S, Forslund S, Chechi K, Aron-Wisnewsky J, Chakaroun R, Nielsen T . Microbiome and metabolome features of the cardiometabolic disease spectrum. Nat Med. 2022; 28(2):303-314. PMC: 8863577. DOI: 10.1038/s41591-022-01688-4. View

Kim M, Kang S, Park J, Yanagisawa M, Kim C . Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013; 145(2):396-406.e1-10. DOI: 10.1053/j.gastro.2013.04.056. View

Li X, Wang Z, cajka T, Buffa J, Nemet I, Hurd A . Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI Insight. 2018; 3(6). PMC: 5926943. DOI: 10.1172/jci.insight.99096. View

Conraads V, Jorens P, De Clerck L, van Saene H, Ieven M, Bosmans J . Selective intestinal decontamination in advanced chronic heart failure: a pilot trial. Eur J Heart Fail. 2004; 6(4):483-91. DOI: 10.1016/j.ejheart.2003.12.004. View

10.

Chambers E, Preston T, Frost G, Morrison D . Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health. Curr Nutr Rep. 2018; 7(4):198-206. PMC: 6244749. DOI: 10.1007/s13668-018-0248-8. View

11.

Shkoporov A, Hill C . Bacteriophages of the Human Gut: The "Known Unknown" of the Microbiome. Cell Host Microbe. 2019; 25(2):195-209. DOI: 10.1016/j.chom.2019.01.017. View

12.

Pluznick J, Protzko R, Gevorgyan H, Peterlin Z, Sipos A, Han J . Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013; 110(11):4410-5. PMC: 3600440. DOI: 10.1073/pnas.1215927110. View

13.

Awoyemi A, Troseid M, Arnesen H, Solheim S, Seljeflot I . Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population. Atherosclerosis. 2019; 286:53-59. DOI: 10.1016/j.atherosclerosis.2019.05.004. View

14.

Offermanns S . Activation of platelet function through G protein-coupled receptors. Circ Res. 2006; 99(12):1293-304. DOI: 10.1161/01.RES.0000251742.71301.16. View

15.

Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M . A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003; 278(11):9435-40. DOI: 10.1074/jbc.M209706200. View

16.

Mayerhofer C, Ueland T, Broch K, Vincent R, Cross G, Dahl C . Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure. J Card Fail. 2017; 23(9):666-671. DOI: 10.1016/j.cardfail.2017.06.007. View

17.

Frostegard J . Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013; 11:117. PMC: 3658954. DOI: 10.1186/1741-7015-11-117. View

18.

Talmor-Barkan Y, Bar N, Shaul A, Shahaf N, Godneva A, Bussi Y . Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nat Med. 2022; 28(2):295-302. DOI: 10.1038/s41591-022-01686-6. View

19.

Khan M, Dirweesh A, Khurshid T, Siddiqui W . Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2018; 30(11):1309-1317. DOI: 10.1097/MEG.0000000000001243. View

20.

Wang D, Doestzada M, Chen L, Andreu-Sanchez S, van den Munckhof I, Augustijn H . Characterization of gut microbial structural variations as determinants of human bile acid metabolism. Cell Host Microbe. 2021; 29(12):1802-1814.e5. DOI: 10.1016/j.chom.2021.11.003. View